Bond.az White LogoBond.az Black Logo

KeyBanc lowers Karman Holdings stock price target

KeyBanc lowered Karman Holdings price target to $100 from $122. Shares down 46% from highs. Analysts cut earnings forecasts.

David Wilson
ByDavid Wilson- Senior Editor
|
0

KeyBanc reduced its price target on Karman Holdings Inc (NYSE:KRMN) to $100 from $122, while maintaining an Overweight rating. Shares currently trade at $64.20, down 46% from the 52-week high of $118.38.

The revision reflects higher near-term investments and integration costs following the first-quarter fiscal 2026 earnings report. Seven analysts have revised earnings downward for the upcoming period, according to market data.

Analyst Michael Leshock stated that the long-term thesis remains intact: “KRMN is well-positioned to capitalize on missile inventory replenishment, space programs, and M&A opportunities.”

Recent results: KRMN met EPS expectations of $0.11 and slightly beat revenue forecasts with $151.2 million, driven by 51% revenue growth.

More News
Today / 11:53
|
435

Stifel Maintains Manhattan Associates Price Target

Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.

0
Today / 11:52
|
256

Rosenblatt Raises 8x8 Target to $3.00

Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.

0
Today / 11:52
|
385

Piper Sandler Reiterates Alphabet Overweight on AI

Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.

0
Today / 11:51
|
464

Rosenblatt Cuts Canaan Target Price to $1.30

Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.

0
Today / 11:50
|
872

Bernstein raises Dell target to $280 on AI

Bernstein raises Dell price target to $280, citing agentic AI demand and SMCI share losses.

0
Today / 11:43
|
228

Alpha Tau Stock Gets Buy Rating, $15 Target

H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.

0
Today / 11:42
|
472

H.C. Wainwright Reiterates Protara Buy Rating

H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.

0
Today / 11:41
|
612

H.C. Wainwright reiterates MindWalk stock rating on platform validation

H.C. Wainwright reiterates Buy rating and $5 target on MindWalk stock, citing platform validation and strong pipeline. Read more.

0
Today / 11:40
|
376

Traws Pharma Gets $8 Price Target from H.C. Wainwright

H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.

0
Today / 11:33
|
664

Morgan Stanley raises ZTO target to $30.10

Morgan Stanley raises ZTO Express price target to $30.10 from $28.50, maintains Overweight rating, citing profit growth outlook.

0
Today / 11:33
|
701

Guggenheim reiterates Buy rating on Okta stock

Guggenheim reiterates Buy rating on Okta stock with $138 price target. Analysts expect Q1 earnings to beat consensus.

0
Today / 11:32
|
805

BTIG Lowers ServiceTitan Target, Keeps Buy

BTIG lowered ServiceTitan price target to $90 from $105, maintains Buy rating. Revenue growth 24.5%, gross margins 70%.

0
...